# Brigham and Women's Hospital

Type: organization

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/brigham-and-womens-hospital
Canonical HTML page: https://gethealthbrief.com/entity/brigham-and-womens-hospital

## Timeline

- **2026-07-16**: NPR Analysis Reveals Limited Coverage — Analysis finds only 92 drug deals, covering fewer than 12% of participating companies' brand-name portfolios.
- **2026-03-09**: Biological Aging Analysis — New data confirms daily supplements slow the ticking of the biological aging clock in older adults.
- **2026-02**: TrumpRx Website Launches — The portal goes live, offering discounts on a subset of brand-name drugs.
- **2025-09**: Voluntary Agreements Reached — Drugmakers agree to participate in a new discount program after closed-door negotiations involving tariff threats.
- **2025-07**: Demand Letters Sent — Administration sends letters to 17 drug companies demanding lower prices and direct-to-consumer sales, threatening tariffs if not met within 60 days.
- **2025-05**: Executive Order Issued — President Trump signs executive order aimed at bringing U.S. drug prices in line with other wealthy countries, setting stage for TrumpRx.
- **2023-05-24**: COSMOS-Web Study — Research published in the American Journal of Clinical Nutrition linked multivitamins to improved memory.
- **2021-11-01**: Initial COSMOS Results — Early data focused on cardiovascular and cancer outcomes showed neutral results for multivitamins.

## Recent coverage (2 stories)

### TrumpRx: 92 Drug Deals Cover <12% of Brand-Name Portfolio
2026-07-16 13:45:20 · Sentiment: Neutral · Impact: 6/10 · Sources: 12

Six months after launch, the government’s TrumpRx drug discount portal offers just 92 brand-name medications—less than 12% of products from participating pharma firms—leaving gaps in cancer, HIV, and inflammatory disease treatments. Health policy experts question its scalability as a long-term cost-containment tool.
Full story: https://gethealthbrief.com/story/trumprx-92-deals-cover-less-than-12-percent

### COSMOS Trial Data Links Daily Multivitamins to Slower Biological Aging
2026-03-09 17:35:07 · Sentiment: Bullish · Impact: 6/10 · Sources: 2

A prespecified analysis of the COSMOS trial reveals that daily multivitamin-multimineral supplements significantly slow markers of biological aging in older adults. The findings provide clinical weight to the use of common supplements as a low-cost intervention for extending biological healthspan.
Full story: https://gethealthbrief.com/story/multivitamins-slow-biological-aging-cosmos-trial

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.